Hi Barman76, 2021 financial year is about to start in a couple of months, so you couldn’t be more spot on
I feel we are moving into a virtuous circle: priority review granted by FDA for Ryoncil, which in turn is regarded by renowned scientists, medical bodies and FDA... as a potential therapy for Covid19/ ARDS, successful trials, increased media awareness, SP going up which would qualify for ASX 200 listing in the coming rebalance...
Stars are aligning
I'm Calling it!, page-6
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.49 |
Change
0.140(10.4%) |
Mkt cap ! $1.701B | |||
| Open | High | Low | Value | Volume |
| $1.37 | $1.54 | $1.37 | $23.10M | 15.82M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 24758 | $1.49 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.49 | 73626 | 3 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |